Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial-Reference-Cited by-同舟云学术

Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial

Published:2009-09 Issue:3 Volume:54 Page:459-467
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Akizawa Tadao,Asano Yasushi,Morita Satoshi,Wakita Takafumi,Onishi Yoshihiro,Fukuhara Shunichi,Gejyo Fumitake,Matsuo Seiichi,Yorioka Noriaki,Kurokawa Kiyoshi

Publisher

Elsevier BV

Subject

Nephrology

Reference20 articles.

1. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats;Nakagawa;Am J Nephrol,2006

2. Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease;Taki;J Ren Nutr,2007

3. An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure;Shimoishi;Pharm Res,2007

4. Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats;Kobayashi;Nephron,2002

5. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure;Okada;Kidney Blood Press Res,2004

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to delay the progression of chronic kidney disease: focusing on medications;Childhood Kidney Diseases;2024-06-13

2. Liquid Chromatography-Mass Spectrometry Analytical Methods for the Quantitation of p-Cresol Sulfate and Indoxyl Sulfate in Human Matrices: Biological Applications and Diagnostic Potentials;Pharmaceutics;2024-05-30

3. Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor;Cellular & Molecular Biology Letters;2024-03-15

4. Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees;Clinical and Experimental Nephrology;2024-02-10

5. Effects of AST-120 on mortality in patients with chronic kidney disease modeled by artificial intelligence or traditional statistical analysis;Scientific Reports;2024-01-06